Does Dextroamphetamine Saccharate Amphetamine Aspartate Monohydra Interact with Urinary Alkalinizing Agents?
Dextroamphetamine Saccharate Amphetamine Aspartate Monohydra and Urinary Alkalinizing Agents have a moderate drug interaction according to U.S. FDA drug labeling data. Increase blood levels and potentiate the action of amphetamine. The mechanism involves alkalinization increases amphetamine absorption and reduces renal elimination. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Dextroamphetamine Saccharate Amphetamine Aspartate Monohydra and Urinary Alkalinizing Agents occurs because alkalinization increases amphetamine absorption and reduces renal elimination. Clinically, this means increase blood levels and potentiate the action of amphetamine. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Dextroamphetamine Saccharate Amphetamine Aspartate Monohydra and your doctor is considering prescribing Urinary Alkalinizing Agents (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider